Assistant Professor, Medicine, MedStar Georgetown University Hospital
Oncology
Dr. Paula R. Pohlmann, MD
|
|
Give Review
Paula R. Pohlmann works in the field of Oncology. She went to Federal University of Rio Grande do Sul School of Medicine. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Paula Pohlmann is a published doctor as well. She has 18 publications published. The latest was: [Mortality from uterine cervix cancer in Rio Grande do Sul]. Paula Pohlmann accepts Medicare payments and is listed with Medicare.gov.
Publications
- Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell Carcinoma.
- Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell Carcinoma.
- Resistance to Trastuzumab in Breast Cancer.
- Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
- Chemotherapy and immunotherapy in metastatic colorectal Cancer.
- Tumor size as a surrogate end point for the detection of early breast Cancer: a 30-year (1972-2002), single-center experience in southern Brazil.
- Optical metabolic imaging of treatment response in human head and neck squamous cell Carcinoma.
- CXCL8 secretion by dendritic cells predicts contact allergens from irritants.
- Accuracy of frozen-section Analysis in the diagnosis of ovarian tumors: a systematic quantitative review.
- [Mortality from uterine cervix Cancer in Rio Grande do Sul].
- [Smoking in Porto Alegre: prevalence and the role of health professionals in its prevention].
- Extended neoadjuvant chemotherapy in locally advanced breast Cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cells.
- Adjuvant platinum-based chemotherapy for early stage cervical Cancer.
- A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid Malignancies.
- Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell Carcinoma of the cervix.
- Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast Cancer.
- A model to optimize public health care and downstage breast Cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort).
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Vanderbilt University -
Federal University of Rio Grande do Sul School of Medicine
Drug Facts
| NPI NUMBER | 1013064823 | |
| NPPES Provider LastName | POHLMANN | |
| NPPES Provider FirstName | PAULA | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 150.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 28.0 | |
| Percent Opioid Claims | 18.67 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013064823 |
| Last Name Of The Provider | POHLMANN |
| First Name Of The Provider | PAULA |
| View All |
Similar Doctors
|
|
Dr. Claudine J. Isaacs, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Louis M. Weiner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert D. Warren, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Suzman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia A. Beaver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepa S. Subramaniam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandra J. Ginsberg, MD
This Doctor is OpenDoctor Recommended.
|